Search

everythinglearnresearchcommunity

for

Search:↓

Targeting the skin's endocannabinoid system could help treat skin disorders.

Understanding how epigenetic regulation affects stem cells is key to cancer insights and new treatments.

New drugs targeting DNA enzymes show promise for cancer treatment but have side effects like immune system suppression and hair loss.

The drugs finasteride and dutasteride reduce low-grade prostate cancers but may double the risk of high-grade cancers.

Blocking the Wnt pathway could lead to new treatments for cancer and tissue repair but requires careful development to avoid side effects.

Targeted cancer therapies can cause skin side effects, which should be treated early to help patients' quality of life and treatment adherence.

Coumarin derivatives show promise as anti-estrogenic agents for treating breast cancer, with some in clinical trials.

TGF-β signaling is crucial for stem cell maintenance, differentiation, and has implications for cancer treatment.

Certain spices may help prevent and treat skin cancer, but more human trials are needed.

The document concludes that understanding and managing hair loss in cancer patients is important, and more research is needed for better treatments.

Tissue-derived extracellular vesicles are crucial for cancer diagnosis, prognosis, and treatment.

FGF signaling is a promising target for developing treatments for wounds, metabolic diseases, and cancer.

Runx1 controls fat-related genes important for normal and cancer cell growth, affecting skin and hair cell behavior.

Short telomeres contribute to aging and cancer, and while telomerase can delay aging, it may also promote cancer.

Nanotechnology is improving drug delivery and targeting, with promising applications in cancer treatment, gene therapy, and cosmetics, but challenges remain in ensuring precise delivery and safety.

Men, particularly those with hair loss, are more likely to get the virus, and those with prostate cancer may have milder symptoms. Testosterone's role in the disease is unclear, and the virus doesn't seem to harm male fertility. Women with PCOS might be at higher risk. More research is needed.

Birth control pills increase certain receptor activities in female gerbil prostate glands and can lead to prostate changes.

Steroid Sulfatase inhibitors show promise in treating hormone-dependent disorders like cancers, hair loss, and acne, with 667COUMATE being a potential candidate for breast cancer treatment trials.

The document reviews 20 U.S. patents from July and August 2004 about new drug forms, cancer treatments, aroma chemicals, statin drugs, and various chemical production methods.

After prostate removal surgery, higher initial prostate size was linked to higher urethral PSA levels and more severe male pattern baldness.

Prostate cancer patients need early psychological and sexual support during radiotherapy to improve their quality of life.

Breast cancer treatments work better with AR activation, improving results and reducing side effects.

Skin reactions from cancer treatments might predict how well the treatments work.

Chrysin makes docetaxel more effective and reduces its side effects in lung cancer treatment.

Some hormone treatments might raise breast cancer risk, while others don't seem to.

Scalp cooling is the only FDA-approved method to prevent hair loss from chemotherapy, but other treatments like minoxidil and PRP are being tested.

Olfactory receptors found outside the nose may offer new treatments for diseases like cancer and help in wound healing and hair growth.

Localized heat or specific injections can prevent chemotherapy-induced hair loss without affecting cancer treatment.

CCT128930 is a promising new drug that effectively targets and inhibits a cancer-related protein, showing potential for cancer treatment.

Drugs targeting the Androgen Receptor are effective for treating prostate cancer and other androgen-related conditions.